¼¼°èÀÇ ÀÇ·á¿ë ÀÏȸ¿ëǰ ½ÃÀå
Medical Disposables
»óǰÄÚµå : 1650740
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 403 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÇ·á¿ë ÀÏȸ¿ëǰ ¼¼°è ½ÃÀå, 2030³â±îÁö 7,311¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â 4,394¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë ÀÏȸ¿ëǰ ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 7,311¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â µ¿¾È ¿¬Æò±Õ 8.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ö¼ú±â±¸ ¹× ¿ëǰÀº CAGR 6.1%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 686¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºØ´ë ¹× »óó µå·¹½Ì ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 1,069¾ï ´Þ·¯ ±Ô¸ð, Áß±¹Àº CAGR 10.1%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ÀÇ·á¿ë ÀÏȸ¿ëǰ ½ÃÀåÀº 2024³â 1,069¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1,101¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGRÀº 10.1%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 7.4% ¹× 8.0%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 8.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÀÇ·á¿ë ÀÏȸ¿ëǰ ½ÃÀå µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë ÀÏȸ¿ëǰÀº ÁÖ»ç±â, Àå°©, ¸¶½ºÅ©, ¼ö¼úº¹ µî ´Ù¾çÇÑ ÀÏȸ¿ë Á¦Ç°À» Æ÷ÇÔÇϸç Çö´ë ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ ÇʼöǰÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ Á¦Ç°µéÀº ¹«±Õ¼ºÀ» º¸ÀåÇÏ°í ±³Â÷ ¿À¿°À» ¹æÁöÇϱâ À§ÇØ ÀÏȸ¿ëÀ¸·Î ¼³°èµÇ¾î °¨¿° °ü¸® ¹× ȯÀÚ ¾ÈÀü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. º´¿ø, Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ÀçÅÃÀÇ·á ȯ°æ µî ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ÀÏȸ¿ëǰÀÇ ÁøÈ­´Â Àç·á °úÇÐÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ¾ÈÀü¼º, À¯È¿¼º, Æí¾ÈÇÔÀ» Çâ»ó½ÃŲ Á¦Ç°À» »ý»êÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÀúÀڱؼº ¼ÒÀç¿Í ¶óÅØ½º ÇÁ¸® ¼ÒÀçÀÇ °³¹ßÀº ¾Ë·¹¸£±â ¹ÝÀÀ ¹®Á¦¸¦ ÇØ°áÇϰí, Ç×±Õ ÄÚÆÃÀÇ Çõ½ÅÀº ÀÏȸ¿ëǰÀÇ º¸È£ ´É·ÂÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ÷´Ü Á¦Á¶ ±â¼úÀÇ ÅëÇÕÀº ´õ ³ôÀº Á¤¹Ðµµ¿Í ǰÁú·Î ÀÏȸ¿ëǰÀ» »ý»êÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ÀÇ·á¿ë Á¦Ç°ÀÇ ½Å·Ú¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

ÀÇ·á¿ë ÀÏȸ¿ëǰÀÇ ¹ø¿µ¿¡ ±â¿©ÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª´Â FDA, CDC, WHO¿Í °°Àº ±ÔÁ¦ ±â°üÀº °¨¿° °ü¸®¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ Áöħ°ú ±âÁØÀ» ¸¶·ÃÇÏ°í ¸¹Àº ÀÇ·á ÀýÂ÷¿¡¼­ ÀÏȸ¿ë ǰ¸ñÀÇ »ç¿ëÀ» Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â ÀÇ·á ÇöÀå¿¡¼­ Å« ¹®Á¦°¡ µÇ°í ÀÖ´Â ÀÇ·á °ü·Ã °¨¿°(HAI)ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ °ÍÀ¸·Î, HAI¸¦ ÁÙÀÌ´Â °ÍÀÌ Áß¿äÇØÁö¸é¼­ ÀÇ·á¿ë ÀÏȸ¿ëǰÀº ¹«±Õ ȯ°æÀ» À¯ÁöÇÏ°í °¨¿° ¿äÀÎÀÇ È®»êÀ» ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ÀÏȸ¿ëǰÀº ¶ÇÇÑ ¸ê±Õ ó¸®ÀÇ Çʿ伺À» ¾ø¾Ö°í °¨¿° °ü¸® ½Ç¹«¿¡¼­ ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á Å« ÆíÀǼº°ú ºñ¿ë È¿À²¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ´Â ½Ã°£°ú È¿À²¼ºÀÌ Áß¿äÇÑ ±Þº¯ÇÏ´Â ÀÇ·á ȯ°æ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¼öÀÇ Áõ°¡¿Í ÀÇ·á ÀýÂ÷ÀÇ º¹À⼺Àº À§»ý°ú ȯÀÚ ¾ÈÀüÀ» À¯ÁöÇÏ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼ö´ÜÀ» Á¦°øÇÏ´Â ÀÏȸ¿ë Á¦Ç°ÀÌ Çö´ë ÀÇ·á ¼­ºñ½º Á¦°ø¿¡¼­ Â÷ÁöÇÏ´Â ¿ªÇÒÀÇ Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ÀÏȸ¿ëǰ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, ¼ÒºñÀÚ Çൿ º¯È­ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ ¾à¹° ¿ëÃâ ½ºÅÙÆ®, »çÀü ÃæÀüµÈ ÁÖ»ç±â, ÷´Ü »óó °ü¸® Á¦Ç° µî º¸´Ù Áøº¸µÈ Ư¼ö ÀÏȸ¿ë Á¦Ç°ÀÌ °³¹ßµÇ¾î Ä¡·á È¿°ú¿Í »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¸¸¼ºÁúȯÀÇ ±ÞÁõ°ú °í·ÉÈ­·Î ÀÎÇØ ƯÈ÷ Àå±â¿ä¾ç ¹× ÀçÅÃÀÇ·á ÇöÀå¿¡¼­ ÀÏȸ¿ë ÀÇ·á¿ëǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû º¯È­·Î ÀÎÇØ ±âÁ¸ ÀÇ·á½Ã¼³ ÀÌ¿ÜÀÇ Àå¼Ò¿¡¼­ ȯÀÚ °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ´ÏÁî°¡ Áõ°¡Çϸ鼭 °¡Á¤¿ë ÀÏȸ¿ë ÀÇ·á¿ëǰ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï±¹À» Áß½ÉÀ¸·Î ÇコÄɾî ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Àü ¼¼°èÀûÀÎ ³ë·ÂÀÌ ÁøÇàµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ Å« µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. À̵é Áö¿ª¿¡¼­´Â ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ¿Í ÀÇ·á ¼­ºñ½º È®´ë·Î ÀÎÇØ ÀÏȸ¿ë ÀÇ·á¿ëǰÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿Ü·¡ ¼ö¼ú ¹× ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í °°Àº ¼ÒºñÀÚ Çൿ Æ®·»µåµµ ÀÇ·á¿ë ÀÏȸ¿ëǰ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡´Â ¼ö¼úÀÇ È¿À²¼º°ú ȯÀÚÀÇ È¸º¹À» µ½´Â Ư¼öÇÑ ÀÏȸ¿ë Á¦Ç°ÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹À¸¸ç, COVID-19 »çÅ ¿ª½Ã ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °³Àκ¸È£Àåºñ(PPE) ¹× ±âŸ ÀÏȸ¿ë ǰ¸ñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí, °¨¿°º´ °ü¸®¿¡¼­ ±× Á߿伺ÀÌ ºÎ°¢µÇ¾ú±â ¶§¹®ÀÔ´Ï´Ù. ÆÒµ¥¹ÍÀº ÀÇ·áÁø°ú ȯÀÚ¸¦ º¸È£ÇÏ´Â ÀÏȸ¿ë Á¦Ç°ÀÇ Çʿ伺À» °­Á¶Çϰí ÀÌ·¯ÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î Áõ°¡½ÃÄ×½À´Ï´Ù.

ºÎ¹®

ºÎ¹®(¼ö¼ú±â±¸ ¹× ¼Ò¸ðǰ, ºØ´ë ¹× »óóġ·áÁ¦, ¼ö¾× ¹× ÇÇÇÏÁÖ»ç±â, Áø´Ü ¹× °Ë»ç ¼Ò¸ðǰ, È£Èí±â¿ëǰ, ¿ä½Ç±Ý¿ëǰ, ºÎÁ÷Æ÷ ÀÇ·á¿ë ÀÏȸ¿ëǰ, Åõ¼®¿ë ¼Ò¸ðǰ, ±âŸ ºÎ¹®)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 87°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Disposables Market to Reach US$731.1 Billion by 2030

The global market for Medical Disposables estimated at US$439.4 Billion in the year 2024, is expected to reach US$731.1 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Surgical Instruments & Supplies, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$68.6 Billion by the end of the analysis period. Growth in the Bandages & Wound Dressings segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Billion While China is Forecast to Grow at 10.1% CAGR

The Medical Disposables market in the U.S. is estimated at US$106.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.1 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Global Medical Disposables Market - Key Trends & Drivers Summarized

Medical disposables, encompassing a broad spectrum of single-use products such as syringes, gloves, face masks, and surgical gowns, have become indispensable in modern healthcare. These items are designed for one-time use to ensure sterility and prevent cross-contamination, playing a critical role in infection control and patient safety. Their utilization spans across various healthcare settings, including hospitals, clinics, ambulatory surgical centers, and home healthcare environments. The evolution of medical disposables has been driven by advancements in material science, resulting in products that offer improved safety, efficacy, and comfort. For instance, the development of hypoallergenic and latex-free materials has addressed issues related to allergic reactions, while innovations in antimicrobial coatings enhance the protective capabilities of disposables. The integration of advanced manufacturing techniques has led to the production of disposables with higher precision and quality, ensuring their reliability and effectiveness in medical applications.

One of the key factors contributing to the prominence of medical disposables is the stringent regulatory framework governing healthcare practices. Regulatory bodies such as the FDA, CDC, and WHO have established comprehensive guidelines and standards for infection control, which mandate the use of disposable items in numerous medical procedures. These regulations are designed to minimize the risk of healthcare-associated infections (HAIs), which are a significant concern in healthcare settings. The growing emphasis on reducing HAIs has led to increased adoption of medical disposables, as they help maintain a sterile environment and prevent the spread of infectious agents. Medical disposables also offer significant convenience and cost-effectiveness, eliminating the need for sterilization processes and reducing the risk of human error in infection control practices. This is particularly important in high-paced medical environments where time and efficiency are critical. Furthermore, the increasing patient load and the complexity of medical procedures underscore the critical role of disposables in contemporary healthcare delivery, as they provide a reliable means of maintaining hygiene and patient safety.

The growth in the medical disposables market is driven by several factors, including technological advancements, rising healthcare expenditures, and changing consumer behaviors. Technological innovations have led to the development of more advanced and specialized disposables, such as drug-eluting stents, prefilled syringes, and advanced wound care products, which offer enhanced therapeutic benefits and ease of use. The surge in chronic diseases and the aging population have heightened the demand for disposable medical supplies, particularly in managing long-term care and home healthcare settings. This demographic shift has resulted in an increased need for products that can facilitate patient care outside of traditional healthcare facilities, driving the market for home-use disposables. Additionally, the ongoing global efforts to improve healthcare infrastructure, especially in emerging economies, have significantly bolstered market growth. Investments in healthcare facilities and the expansion of healthcare services in these regions have led to a greater adoption of disposable medical products. Consumer behavior trends, such as the increased preference for outpatient procedures and minimally invasive surgeries, further contribute to the rising demand for medical disposables. These procedures often require specialized disposables that enhance procedural efficiency and patient recovery. The COVID-19 pandemic has also played a pivotal role in accelerating market growth, as the need for personal protective equipment (PPE) and other disposable items skyrocketed, highlighting their critical importance in managing infectious diseases. The pandemic underscored the necessity of disposables in protecting healthcare workers and patients, leading to a sustained increase in demand for these products.

SCOPE OF STUDY:

The report analyzes the Medical Disposables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Surgical Instruments & Supplies, Bandages & Wound Dressings, Infusion & Hypodermic Devices, Diagnostic & Laboratory Disposables, Respiratory Products, Incontinence Products, Nonwoven Medical Disposables, Dialysis Disposables, Other Segments)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 87 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â